Olivier J. Capitain - Publications

Hybrid ReGex and Natural Language Inference Model as a Zero-Shot Classifier for Extracting Data From Medical Reports.

Journal: JCO clinical cancer informatics

Published: September 22, 2025

PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 16, 2025

Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancer.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 15, 2024

Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial.

Journal: The lancet. Healthy longevity

Published: November 27, 2023

Confounding mitigation for the exposure-response relationship of bevacizumab in colorectal cancer patients.

Journal: British journal of clinical pharmacology

Published: September 25, 2023

Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity.

Journal: Scientific reports

Published: July 12, 2023

Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 16, 2023

Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients.

Journal: Clinical pharmacokinetics

Published: May 28, 2023

Academic carriers in oncology and radiotherapy: Update for the readers of Bulletin du Cancer

Journal: Bulletin du cancer

Published: May 29, 2021

Persistent elevation of plasma vitamin B12 is strongly associated with solid cancer.

Journal: Scientific reports

Published: February 09, 2021

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.

Journal: The Lancet. Oncology

Published: September 25, 2020

Rehabilitation following total laryngectomy: Oncologic, functional, socio-occupational and psychological aspects.

Journal: European annals of otorhinolaryngology, head and neck diseases

Published: June 27, 2020